O. Decaux

1.2k citations

45 papers · 704 indexed · h-index 13

Impact in

Rheumatology top 5%
- Eosinophilic Disorders and Syndromes
Hematology top 10%
- Multiple Myeloma Research and Treatments

Papers in ⓘ

Hematology 17
- Multiple Myeloma Research and Treatments 15
Genetics 10
- Chronic Lymphocytic Leukemia Research 8

Co-authors: P. Jégo (11 shared papers)B. Grosbois (15 shared papers)C. Cazalets (9 shared papers)S. Jouneau (3 shared papers)Jean-François Ménard (2 shared papers)S. Josse (2 shared papers)P. Roblot (2 shared papers)Élisabeth Diot (2 shared papers)
Journals: Annals of the Rheumatic Diseases (3 papers)European Journal of Internal Medicine (3 papers)Leukemia (2 papers)Journal of Inherited Metabolic Disease (1 paper)Autoimmunity Reviews (1 paper)
Partner nations: France United States Taiwan

In The Last Decade

O. Decaux

42 papers receiving 690 citations

Peers

Countries citing papers authored by O. Decaux

Since Specialization

Citations

This map shows the geographic impact of O. Decaux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Decaux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Decaux more than expected).

Fields of papers citing papers by O. Decaux

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Decaux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Decaux. The network helps show where O. Decaux may publish in the future.

Co-authors

The 25 scholars most cited alongside O. Decaux, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with O. Decaux Line = papers co-authored together O. Decaux links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome Autoimmunity Reviews ·Marie Ito, S. Josse, O. Decaux, S. Dominique, Élisabeth Diot, C. Landron, P. Roblot, S. Jouneau, Pierre‐Yves Hatron, K.P. Tiev, O. Vittecoq, Danièle Noël, Luc Mouthon, Jean-François Ménard, F. Jouen	2012	147
2	Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients Lara D. Veeken ·Pierre Charles, A. Néel, N. Tieulié, A. Hot, G. Pugnet, O. Decaux, I. Marie, Mehdi Khellaf, Jean‐Emmanuel Kahn, Alexandre Karras, Jean-Marc Ziza, C. Deligny, Colas Tchérakian, Loı̈c Guillevin, (unknown)	2013	90
3	Minor clone provides a reservoir for relapse in multiple myeloma Leukemia ·Florence Magrangeas, Hervé Avet‐Loiseau, Wilfried Gouraud, Laurence Lodé, O. Decaux, Pascal Godmer, Laurent Garderet, Laurent Voillat, Thierry Façon, Anne Marie Stoppa, Gérald Marit, C. Hulin, Philippe Casassus, Mourad Tiab, Éric Voog, Edouard Randriamalala, K. Anderson, Philippe Moreau, Nikhil Munshi, Stéphane Minvielle	2012	83
4	Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24 Annals of the Rheumatic Diseases ·David Saadoun, (unknown), Vincent Thibault, M. Longuet, S. Pol, F Blanc, Gilles Pialoux, Alexandre Karras, D Bazin-Karra, C. Cazorla, Daniel Vittecoq, L. Musset, O. Decaux, Jean-Marc Ziza, Olivier Lambotte, P. Cacoub	2013	57
5	Clinical manifestations and outcome of anti-PL7 positive patients with antisynthetase syndrome European Journal of Internal Medicine ·Marie Ito, S. Josse, O. Decaux, Élisabeth Diot, C. Landron, P. Roblot, S. Jouneau, P.Y. Hatron, É. Hachulla, Olivier Vittecoq, Jean-François Ménard, F. Jouen, S. Dominique	2013	53
6	Aortites thoraciques infectieuses : implications microbiologiques, physiopathologiques et thérapeutiques La Revue de Médecine Interne ·Matthieu Revest, O. Decaux, C. Cazalets, J.-P. Verohye, P. Jégo, B. Grosbois	2006	48
7	Using Rituximab Plus Fludarabine and Cyclophosphamide as a Treatment for Refractory Mixed Cryoglobulinemia Associated With Lymphoma Arthritis Care & Research ·David Saadoun, Marc Pineton de Chambrun, Olivier Hermine, Alexandre Karras, Sylvain Choquet, P. Jégo, O. Decaux, P. Cacoub	2012	32
8	Traitement des hématomes sous-duraux chroniques par les corticoïdes : à propos de deux observations La Revue de Médecine Interne ·O. Decaux, B. Cador, Thierry Dufour, P. Jégo, C. Cazalets, E. Laurat, B. Grosbois	2002	19
9	Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. A prospective study in 117 patients La Presse Médicale ·Loı̈c Guillevin, Christian Pagnoux, Alexandre Karras, C. Khouatra, O. Aumaître, Pascal Cohen, O. Decaux, H. Desmurs‐Clavel, P. Gobert, T. Quéméneur, Claire Blanchard‐Delaunay, Pascal Godmer, Xavier Puéchal, P.L. Carron, P.Y. Hatron, Nicolas Limal, M. Hamidou, Bernard Bonnotte, Philippe Ravaud, Luc Mouthon	2013	19
10	Current role of CT and whole body MRI in multiple myeloma Diagnostic and Interventional Imaging ·R Duvauferrier, M. Valence, S. Patrat-Delon, É. Brillet, E. Niederberger, A. Marchand, M. Rescan, Raphaël Guillin, O. Decaux	2013	14
11	Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial Leukemia ·Nizar J. Bahlis, Alessandro Corso, L.-O. Mügge, Z-X Shen, P. Desjardins, A.-M. Stoppa, O. Decaux, Thierry de Revel, Miquel Granell, Gérald Marit, Hareth Nahi, H Demuynck, Shang‐Yi Huang, Supratik Basu, Troy H. Guthrie, Annette Ervin‐Haynes, J Marek, G. Chen, Thierry Façon	2017	14
12	Les aortites syphilitiques. Expérience d'un service de médecine interne La Revue de Médecine Interne ·Matthieu Revest, O. Decaux, T. Frouget, C. Cazalets, B. Cador, P. Jégo, B. Grosbois	2005	13
13	Infections à cryptocoque chez des patients non VIH. À propos de quatre cas et revue de la littérature La Revue de Médecine Interne ·Matthieu Revest, O. Decaux, T. Frouget, C. Cazalets, Jean-David Albert, S. Chevrier, Claude Guiguen, P. Jégo, B. Grosbois	2005	12
14	Épidémiologie descriptive des gammapathies monoclonales. Expérience d'un centre hospitalier général et d'un service de médecine interne de centre hospitalier et universitaire La Revue de Médecine Interne ·O. Decaux, Philippe Rodon, A. Ruelland, L. C. Estepa, R Leblay, B. Grosbois	2007	8
15	OP0213 Rituximab Versus Azathioprine for Maintenance in Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis (MAINRITSAN): Follow Up at 34 Months Annals of the Rheumatic Diseases ·Benjamin Terrier, Christian Pagnoux, A. Karras, C. Khouatra, O. Aumaître, P. Cohen, F. Maurier, O. Decaux, H. Demurs-Clavel, P. Gobert, T. Quéméneur, Pascal Godmer, Xavier Puéchal, Luc Mouthon, Loı̈c Guillevin	2013	8
16	Épidémiologie descriptive des amyloses diagnostiquées au CHU de Rennes de 1995 à 1999 La Revue de Médecine Interne ·C. Cazalets, B. Cador, N Mauduit, O. Decaux, M.P. Ramée, P. Le Pogamp, Marcel Laurent, P. Jégo, B. Grosbois	2003	7
17	Heavy/light chain specific immunoglobulin ratios provides no additional information than serum proteins electrophoresis and immunofixation for the diagnosis and the follow-up of intact immunoglobulin multiple myeloma patients Pathologie Biologie ·M.-P. Beaumont-Epinette, Caroline Moreau, Sophie Besnard, F. Latute, Nicolas Collet, M. Sébillot, B. Grosbois, Claude Bendavid, Lucienne Guenet, O. Decaux	2015	7
18	Efficacité du rituximab dans les hémophilies acquises : à propos de deux cas et revue de la littérature La Revue de Médecine Interne ·Arnaud Millet, O. Decaux, B. Bareau, Benoît Guillet, C. Cazalets, Antoinette Perlat, P. Jégo, B. Grosbois	2007	6
19	Les manifestations pulmonaires du syndrome des antisynthétases Revue des Maladies Respiratoires ·S. Jouneau, B. Hervier, Étienne-Marie Jutant, O. Decaux, M. Kambouchner, Marc Humbert, P. Delaval, David Montani	2014	6
20	Rituximab versus azathioprine for maintenance in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (MAINRITSAN): Follow-up at 34 months La Presse Médicale ·Benjamin Terrier, Christian Pagnoux, Alexandre Karras, C. Khouatra, O. Aumaître, Pascal Cohen, F. Maurier, O. Decaux, H. Desmurs‐Clavel, P. Gobert, T. Quéméneur, Claire Blanchard‐Delaunay, Pascal Godmer, Xavier Puéchal, Luc Mouthon, Loı̈c Guillevin	2013	6

About O. Decaux

O. Decaux is a scholar working on Hematology, Genetics, Rheumatology, Family Practice and Pathology and Forensic Medicine, having authored 45 papers that have together received 704 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (15 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (9 papers), Chronic Lymphocytic Leukemia Research (8 papers), Vasculitis and related conditions (4 papers), Lysosomal Storage Disorders Research (3 papers), Autoimmune Bullous Skin Diseases (3 papers), Inflammatory Myopathies and Dermatomyositis (3 papers) and Peripheral Neuropathies and Disorders (3 papers). The work is most often cited by research in Rheumatology (200 citations), Hematology (145 citations), Genetics (103 citations), Pulmonary and Respiratory Medicine (268 citations) and Hepatology (64 citations). O. Decaux has collaborated with scholars based in France, United States and Taiwan. Frequent co-authors include P. Jégo, B. Grosbois, C. Cazalets, S. Jouneau, Jean-François Ménard, S. Josse, P. Roblot, Élisabeth Diot, S. Dominique and Marie Ito. Their work appears in journals such as Annals of the Rheumatic Diseases, European Journal of Internal Medicine, Leukemia, Journal of Inherited Metabolic Disease and Autoimmunity Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact